Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101
Authors
Keywords
Inflammation, Hepatocellular carcinoma, Cancer treatment, Blood counts, Total cell counting, Prognosis, Lymphocytes, Adenoviruses
Journal
PLoS One
Volume 12, Issue 3, Pages e0174769
Publisher
Public Library of Science (PLoS)
Online
2017-03-30
DOI
10.1371/journal.pone.0174769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study
- (2015) Chia-Yang Hsu et al. ANNALS OF SURGICAL ONCOLOGY
- Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
- (2015) Xiao-jun Lin et al. BMC CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation
- (2015) Tomoyuki Abe et al. HEPATOLOGY RESEARCH
- p53 gene therapy-based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study
- (2015) Ai Shen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma
- (2015) Chuan Li et al. JOURNAL OF SURGICAL RESEARCH
- Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization
- (2015) Dong-Sheng Zhou WORLD JOURNAL OF GASTROENTEROLOGY
- Vascular Invasion in Hepatocellular Carcinoma
- (2013) Yun-Hsuan Lee et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Recombinant Human Adenovirus-p53 Injection Induced Apoptosis in Hepatocellular Carcinoma Cell Lines Mediated by p53-Fbxw7 Pathway, Which Controls c-Myc and Cyclin E
- (2013) Kangsheng Tu et al. PLoS One
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- p53gene therapy in combination with transcatheter arterial chemoembolization for HCC: One-year follow-up
- (2011) Yong-Song Guan WORLD JOURNAL OF GASTROENTEROLOGY
- Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study
- (2010) Jun Luo et al. ANNALS OF SURGICAL ONCOLOGY
- Selecting an optimal staging system for hepatocellular carcinoma
- (2010) Chia-Yang Hsu et al. CANCER
- The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer
- (2010) G. Kasymjanova et al. Current Oncology
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
- (2010) Masao Omata et al. Hepatology International
- Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
- (2010) Fidel-David Huitzil-Melendez et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial
- (2009) Geng Tian et al. ANTI-CANCER DRUGS
- Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma
- (2009) Zhi-xiang Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Angiogenesis in liver disease
- (2009) Mercedes Fernández et al. JOURNAL OF HEPATOLOGY
- Novel advancements in the management of hepatocellular carcinoma in 2008
- (2008) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors
- (2008) He Zhang et al. MOLECULAR THERAPY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started